Stock can be one of the largest assets on a community pharmacy’s balance sheet.
It can also be one of the largest consumers of cash.
Yet many pharmacy businesses think about stock primarily when somebody asks for a year-end stocktake figure.
That misses much of its financial importance.
Pharmacy stock accounting affects gross profit, purchasing margin, cash flow, tax, working capital, management accounts and the reliability of the balance sheet.
If stock is valued incorrectly, profit can be wrong.
If supplier credits are missing, cost of sales can be wrong.
If expired or obsolete products remain at full cost in the stock figure, assets can be overstated.
If inventory keeps increasing, a profitable pharmacy can still experience cash pressure.
Pharmacy owners should therefore treat inventory as a continuing financial-management issue rather than an annual accounting adjustment.
HMRC’s current Business Income Manual confirms that one acceptable tax valuation basis is the lower of cost and net realisable value, with FRS 102 and FRS 105 using the equivalent concept of estimated selling price less costs to complete and sell.
Why Pharmacy Stock Is Different From an Ordinary Expense
When a pharmacy purchases inventory, the accounting effect is not necessarily the same as immediately expensing the full purchase against current-period profit.
Unsold stock represents an asset.
The relationship can be understood through the simplified cost-of-sales formula:
Opening stock + purchases − closing stock = cost of goods sold.
Gross profit can then broadly be described as:
Relevant revenue − cost of goods sold = gross profit.
This is why the closing-stock figure has such a direct relationship with profit.
If the stock value is materially wrong, cost of sales may also be materially wrong.
A Simple Example
Suppose a pharmacy has:
opening inventory of £180,000;
purchases of £1,200,000;
and closing inventory of £200,000.
Ignoring other adjustments, cost of sales would be:
£180,000 + £1,200,000 − £200,000 = £1,180,000.
Now imagine that closing stock was accidentally overstated by £30,000.
The accounts would show closing stock of £230,000.
Cost of sales would fall to £1,150,000.
That could overstate gross profit by £30,000 in this simplified example.
The pharmacy has not actually become £30,000 more profitable.
The stock figure simply changed the reported result.
That demonstrates why stocktake quality and valuation methodology matter.
What Does “Cost” Mean for Pharmacy Inventory?
HMRC guidance describes inventory cost broadly as including costs of purchase, conversion and other costs incurred in bringing inventory to its current location and condition.
For pharmacy owners, this means the ledger should properly reflect the actual purchasing economics.
Supplier invoices are only one part of the information.
Depending on the arrangements, the business may also need to account accurately for:
credit notes;
returns;
discounts;
rebates;
and other adjustments affecting purchase cost.
If significant supplier credits are omitted from the books, purchases may appear higher than they really are.
This can distort gross profit.
Strong supplier reconciliation is therefore a stock-accounting control as well as a bookkeeping control.
Lower of Cost and Net Realisable Value
Stock is not automatically carried forever at historical cost.
Where its realisable value has fallen below cost, a write-down may be required under the relevant accounting principles.
HMRC explains that net realisable value can fall because of deterioration, obsolescence or changes in demand.
That is highly relevant to pharmacies.
Inventory can lose value because:
the product expires;
packaging is damaged;
the line is discontinued;
consumer demand changes;
the item becomes obsolete;
the expected selling price falls;
or the pharmacy is unlikely to realise its original purchase cost.
The accounts should reflect commercial reality rather than simply retaining an old purchase price.
Slow-Moving Stock Does Not Automatically Mean Worthless Stock
There is an important distinction here.
Slow movement can indicate that inventory may be worth less than cost.
But the fact that something sells slowly does not automatically mean its net realisable value has fallen.
HMRC’s guidance makes this point expressly. Slow-moving stock may indicate potential impairment, but it must still be assessed realistically.
This prevents arbitrary write-offs.
A pharmacy should not simply write down every product that has not moved within ninety days by 50% because doing so produces a more favourable tax result.
The valuation needs a reasonable accounting basis.
Expired Pharmacy Stock
Expired medicines and retail products need particular attention.
If an item can no longer be sold or dispensed and has no recoverable value, continuing to carry it at full cost would ordinarily fail to reflect economic reality.
The pharmacy should have processes to identify expired products and record their financial impact.
This is useful for more than accounting.
Repeated expiry write-offs can reveal weaknesses in:
ordering;
stock rotation;
demand forecasting;
branch transfers;
or range management.
A write-off report can therefore become an operational KPI.
Instead of simply recording:
“£8,000 expired stock adjustment”,
management should ask why £8,000 expired.
Prescription Inventory and Retail Inventory Are Financially Different
It can be useful to distinguish dispensary stock from retail stock for internal reporting.
Prescription inventory is heavily influenced by prescribing patterns, availability, reimbursement and medicine procurement.
Retail stock is more directly influenced by customer demand, product range, pricing and merchandising.
High-value medicines also create a different working-capital profile from ordinary fast-moving retail goods.
If all of those categories are combined into one stock number, the owner loses useful information.
This does not mean every tablet or shampoo needs a separate accounting ledger.
It means management reporting should contain enough classification to explain significant inventory behaviour.
High-Value Medicines and Working Capital
A relatively small number of high-value products can consume substantial cash.
Imagine a pharmacy purchasing several expensive medicines shortly before its wholesaler account becomes payable.
The pharmacy may not yet have received the corresponding reimbursement.
For that period, the pharmacy is financing the inventory.
The financial questions include:
when the medicine is purchased;
when supplier payment is due;
when NHS reimbursement is expected;
whether the product can be returned if circumstances change;
and how much cash is tied up during the cycle.
These are working-capital questions.
This is why stock should be visible in cash forecasting rather than treated solely as a year-end balance-sheet item.
Pharmacy Stock and Medicine Margin
Stock accounting also influences the pharmacy’s understanding of medicine margin.
For England, the 2026/27 CPCF increased the sector’s retained medicine-margin allocation to £1.1 billion.
That is a national funding amount.
It should not be interpreted as a guaranteed gross-margin percentage for an individual pharmacy.
Individual purchasing performance depends on factors including acquisition costs, product mix, reimbursement and supplier arrangements.
A pharmacy therefore needs its own gross-margin information.
The owner should be able to compare purchasing performance across periods and investigate unexpected changes.
Link here to Kudos Accounting’s Community Pharmacy CPCF 2026/27 guide for additional funding context.
Gross Profit Should Be Analysed, Not Merely Calculated
An accountant can calculate gross profit.
The management value comes from explaining why it changed.
Suppose gross margin falls materially between two quarters.
Possible causes include:
increased medicine purchase costs;
a different prescription mix;
supplier changes;
reimbursement movements;
fewer credits or rebates;
retail mix;
stock write-offs;
incorrect stock counts;
or bookkeeping errors.
The owner should not automatically conclude that buying performance deteriorated.
The first step is reconciling the components.
Supplier Credits and Rebates
Supplier credits can easily distort the accounts if they are not recorded in the correct period.
A pharmacy may physically return stock.
The stock leaves the premises.
But if the corresponding credit note is not received or posted, purchases remain overstated.
That can reduce reported gross profit.
The pharmacy should therefore track the lifecycle of material returns:
stock returned;
supplier acknowledgement;
credit expected;
credit received;
credit posted;
supplier account reconciled.
This is basic accounting control, but its effect on margin can be significant.
Supplier Statement Reconciliation
Supplier statements should be reconciled regularly.
The process can identify:
missing invoices;
missing credits;
duplicate transactions;
payments not allocated;
returns not processed;
and differences between the supplier’s records and the pharmacy’s ledger.
A pharmacy with large wholesaler accounts should not wait until year end to discover that its purchase ledger does not agree.
Reliable healthcare bookkeeping provides the underlying records needed for this control.
Physical Stocktake Controls
The stocktake is not merely counting boxes.
It needs a controlled process.
The pharmacy should establish a clear counting date and cut-off.
Staff should understand how to treat goods received around the stocktake date.
Damaged and expired stock should be identified separately.
High-value products deserve particular care.
Transfers between branches need to be captured correctly.
Material discrepancies between physical counts and system records should be investigated.
The final stock valuation should then reconcile to the count information.
A large unexplained stock adjustment should not simply be posted to the accounts without review.
Cut-Off Errors
Stock accounting depends on timing.
Suppose goods arrive immediately before year end but the supplier invoice is not received until the following month.
The pharmacy may own the inventory at the reporting date even though the invoice has not yet been processed.
Or stock may have been returned to a wholesaler immediately before year end but the credit note arrives later.
The accounts need to reflect the underlying transaction in the correct period.
Poor cut-off can distort both inventory and liabilities.
This is why year-end stock procedures should be coordinated with purchase-ledger and supplier-reconciliation work.
Stock Transfers Between Pharmacy Branches
Multi-site pharmacy groups face additional challenges.
Stock may be transferred between branches.
From a group perspective, this is not an external sale.
But branch management accounts may need to recognise movement so each site’s inventory is correct.
Weak transfer controls can create situations where:
one branch records stock leaving;
another branch fails to record receipt;
the group total is wrong;
or branch margin calculations become distorted.
The group should have a standard transfer procedure and reconciliation process.
Retail Stock and Shelf Productivity
Retail inventory should also be considered commercially.
Two products may both generate £500 of annual gross profit.
One turns over every few weeks.
The other occupies shelf space for an entire year.
Those products do not have the same working-capital characteristics.
Useful internal measures can include:
stock turn;
stock days;
gross margin by product category;
slow-moving lines;
and stock value by category.
The objective is not to reduce inventory blindly.
It is to identify stock that consumes cash without producing sufficient return.
Seasonal Inventory
Pharmacies can also hold seasonal products.
Demand may increase during winter, allergy season or other predictable periods.
Seasonal buying can be commercially sensible.
The risk arises when products remain unsold after the relevant period and are carried forward without management review.
That can increase slow-moving inventory and ultimately expiry risk.
Historical sales data can help inform ordering.
Again, accounting and operational information should work together.
Stock Shrinkage
Inventory differences do not always arise because of expiry.
Other causes can include:
damage;
theft;
recording errors;
unrecorded transfers;
unprocessed returns;
incorrect deliveries;
or counting errors.
Repeated unexplained shrinkage is an internal-control issue.
The pharmacy should investigate patterns.
A larger group may wish to consider stronger financial-control testing or internal audit support where inventory and purchasing risks are material.
Stock and VAT
Inventory accounting and VAT accounting are related but separate.
Different pharmacy products and activities can carry different VAT treatments.
Where the pharmacy is partially exempt, VAT recovery on certain costs may also be restricted.
The gross cost recorded in management information may therefore differ depending on whether VAT is recoverable.
That matters when analysing real margins.
For example, an expense that appears to cost £10,000 excluding VAT may economically cost more where part of the VAT is irrecoverable.
This is another reason why pharmacy stock, VAT and management accounting should not operate as three disconnected processes.
The natural supporting internal link is Kudos Accounting’s VAT specialist service.
Stock Is Not the Same as a General Pharmacy Expense
Your website already has a page discussing tax-deductible pharmacy business expenses.
Keep that page focused on the deductible-expense search intent.
This article should not turn into another expenses guide.
Inventory is different because unsold stock may remain an asset and feed through the cost-of-sales calculation rather than simply being treated as an immediate operating expense.
Maintaining that distinction also protects against keyword cannibalisation.
Stock Days
Where reliable information exists, pharmacy owners may use stock days as a management KPI.
The calculation expresses inventory in relation to the relevant cost of sales.
Its usefulness comes mainly from trend.
Suppose the pharmacy historically carries around a certain level of inventory relative to activity.
Stock days then begin increasing significantly.
Management can investigate whether:
the business deliberately increased safety stock;
supplier availability changed;
stock controls weakened;
slow-moving products accumulated;
or dispensing activity fell.
The number provides the prompt.
It does not provide the explanation.
Stock Turn
Inventory turnover is another possible measure.
Again, use consistent definitions.
A high turnover is not automatically good if availability suffers.
A low turnover is not automatically bad if the pharmacy intentionally holds specialist items.
KPIs need context.
The best comparison is often the pharmacy against its own historical performance, supplemented by category-level understanding.
Gross-Margin Reconciliation
When margin changes unexpectedly, the pharmacy should perform a structured reconciliation.
Start with the previous period’s margin.
Then consider known changes in:
purchase prices;
supplier terms;
reimbursement;
product mix;
retail sales;
stock adjustments;
rebates;
credits;
and write-offs.
This creates an explanation for the movement rather than simply reporting a new percentage.
For multi-site groups, perform this analysis at branch level where possible.
A group margin can hide deterioration at one location.
Monthly Stock Reporting
An annual stocktake is not enough for financial management.
Monthly management information may not require a full physical stocktake every month, but the pharmacy should still monitor available inventory data.
At minimum, management should understand:
current stock value;
movement against prior periods;
material high-value items;
known write-offs;
slow-moving products;
and any unusual purchasing movements.
The reporting process should fit the systems available.
The important point is that stock does not disappear from management attention for eleven months.
When Stock Grows Faster Than Revenue
This is a useful warning signal.
Suppose inventory grows by 30% over a year while revenue grows by 5%.
That does not automatically mean there is a problem.
The pharmacy may have intentionally changed purchasing strategy.
But management should understand why the difference exists.
Potential causes include:
more expensive medicine mix;
intentional bulk buying;
supplier shortages;
expansion;
weak ordering;
slow-moving retail products;
or inaccurate stock valuation.
The accounting records should allow the owner to distinguish between them.
Stock and Cash-Flow Forecasting
Purchasing decisions directly affect cash.
A pharmacy preparing a twelve-week or monthly cash forecast should incorporate material medicine purchases and expected supplier payments.
This is particularly important when the business is:
expanding;
refurbishing;
repaying debt;
acquiring another pharmacy;
or experiencing margin pressure.
Cash-flow forecasting connects profitability with liquidity.
A pharmacy can afford an expenditure in profit terms but still be unable to fund it comfortably in cash terms at the planned time.
Pharmacy Acquisition Due Diligence
Inventory becomes particularly important during acquisitions.
A buyer should understand:
how stock is measured;
historical stock levels;
slow-moving inventory;
expired items;
high-value lines;
supplier terms;
gross-margin trends;
and whether reported purchasing performance can be supported.
The sale agreement may also determine how stock at completion is valued.
This needs professional and legal advice specific to the transaction.
The accounting principle is that stock should not be treated as an insignificant afterthought when a large amount of working capital is involved.
Pharmacy Sale Preparation
The seller also benefits from strong inventory records.
Imagine discovering during due diligence that:
stock counts cannot be reconciled;
significant expired stock remains in the system;
supplier credits are missing;
and reported margin fluctuates without explanation.
That can reduce buyer confidence.
Cleaning up inventory controls before marketing the pharmacy can therefore improve the quality of the financial information presented during a transaction.
The Monthly Stock Control Meeting
Stock deserves a short section in the monthly finance review.
Ask:
Has total inventory increased?
Why?
Have purchasing costs changed?
Has gross margin changed?
Are supplier credits complete?
Is there material expiring stock?
Are high-value products increasing working-capital requirements?
Do physical/system differences need investigation?
What action should be taken before the next month?
These questions are more commercially useful than simply asking whether the year-end stocktake has been booked.
How a Specialist Pharmacy Accountant Can Help
A specialist pharmacy accountant should understand that inventory does not sit in isolation.
It connects to:
NHS reimbursement;
supplier purchasing;
cost of sales;
gross margin;
VAT;
working capital;
tax;
and management accounts.
The role can include helping to ensure that the accounting structure gives owners useful information rather than merely producing a year-end balance-sheet number.
This article should therefore contain one strong contextual link to the parent Pharmacy Accountants page.
Do not over-optimise the link.
The purpose of the cluster is:
Pharmacy Accountant pillar → Pharmacy Stock Accounting supporting article → related NHS reimbursement, VAT, bookkeeping and expense articles.
That creates topical depth without having every URL compete for the same query.
Final Takeaway
Pharmacy inventory deserves ongoing financial attention.
Accurate stock accounting helps management understand:
gross profit;
medicine purchasing;
working capital;
cash flow;
supplier performance;
write-offs;
and the reliability of year-end profit.
The objective is not simply to produce a number for the annual accounts.
It is to understand how efficiently the pharmacy is converting money invested in stock into revenue, margin and ultimately cash.
HMRC’s current stock guidance supports the lower-of-cost-and-net-realisable-value principle and specifically recognises deterioration, obsolescence, changes in demand and slow-moving inventory as relevant considerations when assessing value.
Editorial note: This article provides general accounting information. Inventory valuation and tax treatment should be considered using the applicable accounting framework and the facts of the individual business.
Frequently Asked Questions
Answers to common questions about pharmacy stock accounting, inventory valuation, gross profit and medicine purchasing.
How does pharmacy stock affect gross profit?
How should pharmacy stock be valued?
What happens to expired pharmacy stock in the accounts?
Does slow-moving stock always need to be written down?
Why should pharmacy owners monitor stock throughout the year?
Can a pharmacy accountant help with stock and gross-margin reporting?
Do You Know How Much Cash and Profit Are Tied Up in Your Pharmacy Stock?
Accurate inventory reporting can expose margin pressure, slow-moving stock, supplier issues and working-capital problems before they become obvious in the year-end accounts.
- Reconcile purchases, returns and supplier credits.
- Monitor pharmacy gross margin throughout the year.
- Identify slow-moving, expired and high-value inventory.
- Improve stock and working-capital visibility.
- Investigate unexplained changes in purchasing margin.
- Build more reliable pharmacy management accounts.
Get clearer financial control over your pharmacy
Kudos Accounting supports pharmacies with specialist accounting, bookkeeping, tax, VAT, payroll and management reporting. Learn more about our pharmacy accountant services.
Book a Free Consultation →